Wednesday, August 12, 2015 10:13:19 PM
The results of the Scarpa study were extraordinary by any measure. Some of us are doing a lot of work to see if we can find studies to which we can compare this study. The trouble is that most studies that we find are with Elaprase, Shire's highly refined and potent version of the human enzyme, iduronate-2-sulfatase (I2S). Elaprase even has glycans in it that extend its half life, likely a significant factor in Elaprase's low dosing amounts of 0.5 mg/kg, one-twelfth of the dose used by Scarpa with MTfp-I2S.
The enzyme that Scarpa and biOasis used, which I understand to be natural I2S, makes it difficult for us to directly compare MTfp-I2S efficacy with any numbers we can find with Elaprase animal studies. I have scientific papers that show Elaprase dosing levels that are all over the place, 30, 40 mg/kg and even higher doses.
When we have one of the world's leading experts involved in this study, as we do with Scarpa, then we can rest assured that he (and biOasis) conducted the study in the way they did for good reasons. Scarpa and the scientists at all of the pharmaceutical companies that are interested in the results, all understand how our results relate to those of Shire's Elaprase.
The bottom line is this - biOasis is in the business of getting drugs into the brain in an efficacious manner. With Scarpa, biOasis has accomplished that, not in only a merely hopeful manner, but in a manner that has very clear commercial possibilities.
Recent BTI News
- The Gross Law Firm Notifies British American Tobacco p.l.c. Investors of a Class Action Lawsuit and Upcoming Deadline - BTI • PR Newswire (US) • 03/22/2024 09:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2024 06:58:11 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2024 10:46:41 AM
- British American Tobacco p.l.c. Sued for Securities Law Violations - Contact The Gross Law Firm Before March 25, 2024 to Discuss Your Rights - BTI • PR Newswire (US) • 03/11/2024 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 05:10:05 PM
- British American Tobacco p.l.c. Class Action: The Gross Law Firm Reminds British American Tobacco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2024 - BTI • PR Newswire (US) • 03/07/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2024 05:42:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 04:46:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/01/2024 03:52:57 PM
- Form CERT - Certification by an exchange approving securities for listing • Edgar (US Regulatory) • 02/28/2024 01:56:31 PM
- The Gross Law Firm Reminds British American Tobacco Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2024 - BTI • PR Newswire (US) • 02/26/2024 10:45:00 AM
- The Gross Law Firm Notifies Shareholders of British American Tobacco p.l.c.(BTI) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 02/22/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 04:59:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/13/2024 04:10:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/13/2024 01:24:07 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 11:03:23 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:46:32 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/09/2024 09:48:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/09/2024 05:14:59 PM
- Investors who lost money on British American Tobacco p.l.c.(BTI) should contact The Gross Law Firm about pending Class Action - BTI • PR Newswire (US) • 02/09/2024 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 04:46:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 03:51:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/08/2024 01:04:01 PM
- FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of British American Tobacco p.l.c - BTI • PR Newswire (US) • 02/08/2024 03:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/06/2024 03:44:45 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM